These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3181857)
41. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Khan TI; Kamali F; Kesteven P; Avery P; Wynne H Br J Haematol; 2004 Aug; 126(4):557-64. PubMed ID: 15287950 [TBL] [Abstract][Full Text] [Related]
42. [Self management of peroral anticoagulant therapy in patients with artificial heart valves]. Hasenkam JM; Kimose HH; Grønnesby H; Andersen NT; Halborg J; Attermann J; Knudsen L; Christensen TD; Pedersen AM; Lyngbak M; Pilegaard HK Ugeskr Laeger; 1998 Nov; 160(47):6811-5. PubMed ID: 9835790 [TBL] [Abstract][Full Text] [Related]
43. Results of the performance verification of the CoaguChek XS system. Plesch W; Wolf T; Breitenbeck N; Dikkeschei LD; Cervero A; Perez PL; van den Besselaar AM Thromb Res; 2008; 123(2):381-9. PubMed ID: 18585761 [TBL] [Abstract][Full Text] [Related]
44. Optimizing the efficacy and safety of oral anticoagulant therapy: high-quality dose management, anticoagulation clinics, and patient self-management. Ansell JE Semin Vasc Med; 2003 Aug; 3(3):261-70. PubMed ID: 15199459 [TBL] [Abstract][Full Text] [Related]
45. Self-care in sickness and in health. Antrobus M Community Outlook; 1981 Oct; ():342-50, 357. PubMed ID: 6913461 [No Abstract] [Full Text] [Related]
46. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206 [TBL] [Abstract][Full Text] [Related]
47. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Braun S; Watzke H; Hasenkam JM; Schwab M; Wolf T; Dovifat C; Völler H Thromb Haemost; 2007 Feb; 97(2):310-4. PubMed ID: 17264962 [TBL] [Abstract][Full Text] [Related]
49. [What can be expected today from long-term anticoagulation for cardiac and arterial thrombosis?]. Loeliger EA Schweiz Med Wochenschr; 1985 Oct; 115(43):1483-95. PubMed ID: 3909383 [TBL] [Abstract][Full Text] [Related]
50. MCOs following innovative CMS remote monitoring initiative: self-testing service is designed to lower costs and improve outcomes for anticoagulation therapy. Albrecht R Manag Care Q; 2006; 14(1):13-6. PubMed ID: 17590971 [TBL] [Abstract][Full Text] [Related]
51. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing. van den Besselaar AM J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109 [TBL] [Abstract][Full Text] [Related]
52. Important aspects of self-management education in patients with diabetes. Stam DM; Graham JP Pharm Pract Manag Q; 1997 Jul; 17(2):12-25. PubMed ID: 10168174 [TBL] [Abstract][Full Text] [Related]
54. Self-test for pro-times: some day, for some patients. Titus K CAP Today; 1996 Oct; 10(10):5-7. PubMed ID: 10166414 [No Abstract] [Full Text] [Related]
55. What the patient needs to know about anticoagulant drugs. Gerbino PP Am J Pharm Sci Support Public Health; 1977; 149(5):138-44. PubMed ID: 613843 [No Abstract] [Full Text] [Related]
57. Educating patients in self-management of epistaxis in an anticoagulation clinic. Hassenplug KL; Burkiewicz JS; Jackson TL; Peppers LR Am J Health Syst Pharm; 2006 May; 63(10):909-11. PubMed ID: 16675647 [No Abstract] [Full Text] [Related]